MINIPRESS TABLET 5MG

Country: Malaysia

Bahasa: Inggeris

Sumber: NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

Beli sekarang

Risalah maklumat Risalah maklumat (PIL)
29-05-2019
Ciri produk Ciri produk (SPC)
05-09-2016

Bahan aktif:

PRAZOSIN HYDROCHLORIDE

Boleh didapati daripada:

PFIZER (MALAYSIA) SDN. BHD.

INN (Nama Antarabangsa):

PRAZOSIN HYDROCHLORIDE

Unit dalam pakej:

100 Tablet Tablets

Dikeluarkan oleh:

PHARMANIAGA MANUFACTURING BERHAD

Risalah maklumat

                                Pfizer Confidential
_CONSUMER MEDICATION INFORMATION LEAFLET (RIMUP)_
MINIPRESS
®
TABLET
Prazosin Hydrochloride (1 mg, 2 mg & 5 mg)
2
WHAT IS IN THIS LEAFLET?
1.
What MINIPRESS is used for
2.
How MINIPRESS works
3.
Before you use MINIPRESS
4.
How to use MINIPRESS
5.
While you are using it
6.
Side effects
7.
Storage and Disposal of
MINIPRESS
8.
Product Description
9.
Manufacturer and Product
Registration Holder
10.
Date of revision
11.
Serial Number
WHAT MINIPRESS IS USED FOR
MINIPRESS is one of a group of
medicines called alpha-blockers.
It is usually used to treat high blood
pressure (hypertension). It may also be
used to treat heart failure (left ventricle-
related), painful cold fingers (Raynaud’s
Disease) or mild enlargement of the
prostate gland (Benign prostatic
hyperplasia) in men.
HOW MINIPRESS WORKS
In patients with high blood pressure
(hypertension) MINIPRESS works by
relaxing blood vessels (more on
peripheral vessels) so that blood passes
through them more easily. It can be used
alone or in combination with other drugs
used to treat hypertension.
In patients with heart failure,
MINIPRESS works by relaxing the main
blood vessels of the heart, allowing the
heart to pump blood more easily.
MINIPRESS is usually used in heart
failure when other drugs are either no
longer working or have not worked at all.
In patients with Raynaud’s Disease, the
treatment relaxes blood vessels in the
hands, so blood can reach the fingers
more easily. This helps to prevent
coldness and stiffness.
In patients with Benign Prostatic
Hyperplasia, enlargement of the prostate
gland, the medicine is taken to treat the
poor and/or frequent passing of urine.
This is common in patients with
enlargement of the prostate gland. The
treatment works by relaxing muscle
around the bladder and prostate gland so
urine can pass through easily.
You should ask your doctor if you are
unsure why you have been given
MINIPRESS.
BEFORE YOU USE MINIPRESS
- _ When you must not use it _
Do not take MINIPRESS if you:
•
are allergic (hypersensitive) 
                                
                                Baca dokumen lengkap
                                
                            

Ciri produk

                                1
Pfizer Confidential	Pharmaniaga
LPD Title	: MINIPRESS
LPD Date	: 6 January 201	5
Country	: Malaysia
References	: CDS	version	4 dated	11 November 20	14
Reason	: Per RMC of Sep 8, priapism is being added to section 4.4 of the Prazosin
tablets/capsules CDS. Note t	hat priapism is a listed event in section 4.8 of the
CDS and currently is not included in section 4.4 of the CDS. Additionally,
format/editorial changes per recent QC review are being made. For details about
the impact of the CDS	-driven changes into the US	PI refer to the GLDD prepared
for the USPI in the widget related documents tab in the GDMS homepage of the
newly revised USPI.
PFIZER
MINIPRESS*
Prazosin Hydrochloride
1.	NAME OF	THE	MEDICINAL PRODUCT	MINIPRESS
2.	QUALITATIVE AND QUANTITATIVE COMPOSITION
Each	prazosin hydrochloride tablet contains the equivalent of 1 mg	, 2 mg or 5 mg of
prazosin	-free base.
3.	PHARMACEUTICAL FORM	Tablets
Minipress 1 mg Tablet	:
Orange, round, biconvex tablet with ‘K’ brea	kline ‘K’ on one side and Pfizer logo on the
other.
Minipress 2 mg Tablet	:
White, round, biconvex tablet with ‘K’ breakline ‘K’ on one side and Pfizer logo on the
other.
Minipress 5 mg Tablet:
White, diamond shaped tablet with ‘K’ breakline ‘K’ on one si	de and ‘MNP’ breakline
‘5’ on the other.
                                
                                Baca dokumen lengkap
                                
                            

Dokumen dalam bahasa lain

Risalah maklumat Risalah maklumat Bahasa Melayu 29-05-2019

Cari amaran yang berkaitan dengan produk ini